NCT04579380 2025-12-19Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsSeagen Inc.Phase 2 Active not recruiting217 enrolled 19 charts
NCT02006667 2015-02-11A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial CancerHoffmann-La RochePhase 2 Completed13 enrolled 12 charts
NCT02013765 2014-09-25A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial CancerHoffmann-La RochePhase 2 Terminated5 enrolled 12 charts